SelectQuote, Inc. (NYSE: SLQT) is gaining notable traction on the US stock charts today, reflecting positive investor sentiment. Following the announcement of a noteworthy financial milestone, SLQT stock was up 15.60% at $2.60 as of the most recent pre-market check.
SelectQuote Completed the Securitization
SelectQuote declared that it had successfully closed a securitization transaction for $100 million this week. SLQT can advance future financing attempts by using the securitization to leverage projected collections from policies that have already been sold. During this transaction, just a part of SelectQuote’s $1 billion in receivables as of June 30, 2024, were securitized.
The proceeds from the sale will be used to settle a portion of the company’s existing term debt. Notably, the cost of capital for the securitized debt is substantially lower than that of the term loan it replaces.
Extension of Debt Maturity and Strategic Evaluation
This transaction also includes a favorable extension to the maturity of SelectQuote’s remaining term debt, shifting the deadline from September 15, 2025, to September 30, 2027. Furthermore, an additional extension to September 30, 2028, may be granted upon meeting agreed payment milestones.
While future securitization remains a key part of SelectQuote’s strategy for capital restructuring, the company has engaged an investment bank to explore other financial solutions. This strategic review aims to strengthen SelectQuote’s balance sheet, address its payment obligations, and support future investments in core operations.
Expansion of SelectRx Facilities
In terms of operations, SelectQuote aims to construct a third fulfillment center in Olathe, Kansas, as part of its pharmaceutical business, SelectRx. It is anticipated that the 54,000-square-foot, state-of-the-art structure would open next year.
This expansion was planned in response to SelectRx’s membership quickly growing from fewer than 5,000 in 2021 to over 75,000 till the end of this year. The addition of the new facility to the company’s existing sites in Indiana and Pennsylvania will enhance its capacity to offer full-service medication management to its growing clients.